Cargando…

Use of drug-eluting balloon coronary intervention prior to living donor kidney transplantation

BACKGROUND: Kidney transplantation is the gold standard of therapy in patients with terminal renal insufficiency. Living donor transplantation is a well-established option in this field. Enlarging the donor’s pool implicates the acceptance of an increased rate of comorbidities. Among them, coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kammerer, Tobias, Beiras-Fernandez, Andres, Rehm, Markus, Stangl, Manfred, Guba, Markus, Kupatt-Jeremias, Christian, Weis, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162970/ https://www.ncbi.nlm.nih.gov/pubmed/25179749 http://dx.doi.org/10.1186/1471-2261-14-112

Ejemplares similares

Disqualification of Donor and Recipient Candidates From the Living Kidney Donation Program: Experience of a Single-Center in Germany
por: Grigorescu, Melissa, et al.
Publicado: (2022)

Corrigendum: Disqualification of donor and recipient candidates from the living kidney donation program: Experience of a single-center in Germany
por: Grigorescu, Melissa, et al.
Publicado: (2022)

Comparison of rotational atherectomy and modified balloons prior to drug-eluting stent implantation for the treatment of heavily calcified coronary lesions
por: Hong, Xu-Lin, et al.
Publicado: (2021)

Hypoxic-Inflammatory Responses under Acute Hypoxia: In Vitro Experiments and Prospective Observational Expedition Trial
por: Kammerer, Tobias, et al.
Publicado: (2020)

Drug-eluting balloon: is it useful?
por: Laksono, Sidhi, et al.
Publicado: (2020)

A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease
por: Lee, Hak-Il, et al.
Publicado: (2021)

Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection
por: Kemmner, Stephan, et al.
Publicado: (2020)

Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review
por: Richelsen, Rasmus Kapalu Broge, et al.
Publicado: (2016)

One-year outcomes following drug-eluting balloon use for coronary ostial restenosis
por: Lee, Wei-Chieh, et al.
Publicado: (2015)

Sirolimus-Eluting Balloon for the Treatment of Coronary Lesions in Complex ACS Patients: The SELFIE Registry
por: Caiazzo, Gianluca, et al.
Publicado: (2020)

The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty
por: Oh, Pyung Chun, et al.
Publicado: (2016)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Drug eluting balloons for de novo coronary lesions – a systematic review and meta-analysis
por: Fröhlich, Georg M, et al.
Publicado: (2013)

Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials
por: Liu, Lulu, et al.
Publicado: (2018)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2017)

Two Cases of Percutaneous Intervention for Coronary Artery Bypass Graft Anastomoses With Paclitaxel-Eluting Balloon Catheters
por: Uhm, Jae-Sun, et al.
Publicado: (2011)

Cutting-balloon angioplasty before drug-eluting stent implantation for the treatment of severely calcified coronary lesions
por: Tang, Zhe, et al.
Publicado: (2014)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
por: Tsai, Cheng-Hsuan, et al.
Publicado: (2022)

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
por: Funayama, Naohiro, et al.
Publicado: (2022)

ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
por: Ott, Ilka, et al.
Publicado: (2017)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
por: Xiu, Wen-Juan, et al.
Publicado: (2018)

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
por: Beiras-Fernandez, Andres, et al.
Publicado: (2010)

Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
por: Tornyos, Adrienn, et al.
Publicado: (2017)

Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis
por: Murphy, Greg, et al.
Publicado: (2023)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
por: Yang, Yi-Xing, et al.
Publicado: (2023)

Acute- and Long-term Outcomes of Rotational Atherectomy followed by Cutting Balloon versus Plain Balloon before Drug-Eluting Stent Implantation for Calcified Coronary Lesions
por: Ai, Hui, et al.
Publicado: (2018)

Moon phases and moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation
por: Kleespies, A., et al.
Publicado: (2017)

The Randomized Freeway Stent Study: Drug-Eluting Balloons Outperform Standard Balloon Angioplasty for Postdilatation of Nitinol Stents in the SFA and PI Segment
por: Tacke, Josef, et al.
Publicado: (2019)

Cardiovascular outcomes following percutaneous coronary intervention with drug-eluting balloons in chronic kidney disease: a retrospective analysis
por: Jonas, Michael, et al.
Publicado: (2020)

Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study
por: Pellegrini, Dario, et al.
Publicado: (2023)

Correction to: Moon phases and Moon signs do not influence morbidity, mortality and long-term survival, after living donor kidney transplantation
por: Kleespies, A., et al.
Publicado: (2017)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
por: Schönermarck, Ulf, et al.
Publicado: (2011)

Aneurysm formation after paclitaxel-eluting balloon angioplasty used to treat coronary artery restenosis after plain old balloon angioplasty – case report and review of the literature
por: Vassilev, Dobrin, et al.
Publicado: (2015)

Excimer laser coronary atherectomy prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions
por: Shibui, Takashi, et al.
Publicado: (2020)

Comparisons of drug-eluting balloon versus drug-eluting stent for the treatment of cancer patients presenting with acute myocardial infarction
por: Yang, Yi-Xing, et al.
Publicado: (2023)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

The effectiveness and safety of the RESTORE(®) drug-eluting balloon versus a drug-eluting stent for small coronary vessel disease: study protocol for a multi-center, randomized, controlled trial
por: Tang, Yi–Da, et al.
Publicado: (2018)

Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
por: Taherioun, Mehrdad, et al.
Publicado: (2014)

Adverse Events in Primary Percutaneous Coronary Angioplasty With Drug-Eluting Stents Compared With Drug-Coated Balloons: A Retrospective Outlook
por: Sharif Khan, Hamid, et al.
Publicado: (2020)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tnf02t0uqpal30k4lvbcoulkkd